AI assistant
Sending…
Active Biotech — Major Shareholding Notification 2010
Mar 2, 2010
3133_iss_2010-03-02_a48e0a6d-65d1-451b-8d8a-a128fbc70042.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Active Biotech AB (publ)
Holder
195108 Mats Arnhög Genom MGA Holding AB
Instrument
| Instrument | AK SE0001137985 |
|---|---|
| Before the transaction | |
| Shares | 19,224,416 |
| Voting rights | 19,224,416 |
| Transaction | |
| Reason for major shareholding notification Other | |
| Date | 26/02/2010 |
| Limit for number of shares | 30 % |
| Limit for number of votes | 30 % |
| After the transaction | |
| Quantity | |
| Shares | 19,224,416 |
| Directly held voting rights | 19,224,416 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 29.98 % |
| Directly held voting rights | 29.98 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 - Physically settled - Cash settled |
||
| Total | ||
| Published 02/03/2010 09:47 |
||
| Contact | ||
| Phone 040-6645582 Email [email protected] |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Active Biotech
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
AGM Information
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 1
Audit Report / Information
2026
Feb 12
Audit Report / Information
2026
Feb 12
Share Issue/Capital Change
2026
Jan 30